Evolve Global Healthcare Enhanced Yield Fund Hedged UnitsTSX:LIFE
- LAST PRICE20.34
- TODAY'S CHANGE (%)0.14 (0.69%)
- Bid / Lots20.30/ 2
- Ask / Lots20.35/ 25
- Open / Previous Close20.34 / 20.20
- Day Range
- 52 Week Range
- Volume17,919
- Overall Morningstar RatingNot Ratedout of funds
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LIFE |
|---|---|---|
| 09:32 ET | 100 | 20.34 |
| 09:33 ET | 1900 | 20.35 |
| 09:50 ET | 700 | 20.39 |
| 09:57 ET | 200 | 20.36 |
| 10:26 ET | 100 | 20.35 |
| 10:36 ET | 500 | 20.34 |
| 10:47 ET | 800 | 20.34 |
| 11:05 ET | 100 | 20.34 |
| 11:27 ET | 100 | 20.32 |
| 11:30 ET | 1000 | 20.3 |
| 11:36 ET | 100 | 20.32 |
| 12:28 ET | 2200 | 20.36 |
| 12:30 ET | 200 | 20.37 |
| 12:39 ET | 1400 | 20.36 |
| 12:50 ET | 100 | 20.36 |
| 01:06 ET | 500 | 20.36 |
| 01:08 ET | 900 | 20.36 |
| 01:11 ET | 900 | 20.36 |
| 01:13 ET | 100 | 20.37 |
| 01:44 ET | 900 | 20.35 |
| 02:18 ET | 900 | 20.33 |
| 02:50 ET | 900 | 20.36 |
| 03:15 ET | 300 | 20.3 |
| 03:28 ET | 100 | 20.31 |
| 03:32 ET | 100 | 20.31 |
| 03:33 ET | 200 | 20.31 |
| 04:00 ET | 2400 | 20.34 |
| US Equity | 75.1% |
|---|---|
| Int'l Equity | 24.4% |
| Cash | 0.5% |
| CDN Equity | 0 |
| Fixed Income | 0 |
| Other | 0 |
| Healthcare | 99.7% |
|---|---|
| Basic Mat. | 0 |
| Communication Services | 0 |
| Consumer Cyclical | 0 |
| Consumer Defensive | 0 |
| Energy | 0 |
| Financial Serv.s | 0 |
| Industrials | 0 |
| Real Estate | 0 |
| Technology | 0 |
| Utilities | 0 |
| United States | 75.3% |
|---|---|
| Europe | 5.1% |
| Latin America | 0 |
| Africa | 0 |
| Canada | 0 |
| Asia/Oceania | 0 |
| Company Name sortable | Position sortable | Allocation sortable | Allocation sortable1 Month Change | Market Value sortable |
|---|---|---|---|---|
AbbVie Inc | Long | 5.5% | -10.28% | $16.3M |
Intuitive Surgical Inc | Long | 5.4% | -6.90% | $16.0M |
Stryker Corp | Long | 5.2% | -2.79% | $15.4M |
Medtronic PLC | Long | 5.2% | --- | $15.4M |
Johnson & Johnson | Long | 5.2% | -5.39% | $15.3M |
Vertex Pharmaceuticals Inc | Long | 5.2% | +4.02% | $15.2M |
Roche Holding AG ADR | Long | 5.1% | -8.03% | $15.2M |
Abbott Laboratories | Long | 5.1% | -8.57% | $15.1M |
Amgen Inc | Long | 5.1% | +2.83% | $15.0M |
Pfizer Inc | Long | 5.1% | +1.22% | $14.9M |
Reports
Morningstar Ratings
| Time Horizon | Star Rating |
|---|---|
| Overall Rating | Not Rated |
| 3 Year Rating | Not Rated |
| 5 Year Rating | Not Rated |
| 10 Year Rating | Not Rated |
Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.
Style Box is calculated only using the long position holdings of the portfolio.
Best Fit Index | --- |
|---|---|
Category | Sector Equity |
Sponsor | Evolve Funds Group Inc |
Inception | October 23, 2017 |
LIFE seeks to replicate, to the extent reasonably possible before fees and expenses, the performance of the Solactive Global Healthcare 20 Index Canadian Dollar Hedged, or any successor thereto, while mitigating downside risk. LIFE invests primarily in the equity constituents of the Solactive Global Healthcare 20 Index Canadian Dollar Hedged, or any successor thereto, while writing covered call options on up to 33% of the portfolio securities, at the discretion of the Manager. The level of covered call option writing may vary based on market volatility and other factors.
| Total Net Assets | $216.8M |
|---|---|
| Shares Out. | 10.5M |
| Net Asset Value (NAV) | $20.32 |
| Prem/Discount to NAV | 0.12% |
| P/E Ratio | 32.8 |
| Dividend Yield | 10.18% |
| Dividend per Share | 2.07 CAD |
| Ex-Dividend Date | 11/29/2024 |
| Dividend Payment Date | 12/6/2024 |
| Beta | --- |
| Morningstar Investment Style | Sector Equity |
| Equity Style | Large Cap Blend |
| Credit Quality / Duration | --- |
| Actual Management Fee | 0.45% |
|---|---|
| Actual Mgmt. Expense Ratio (MER) | 0.68% |